Dynamic Technology Lab Private Ltd Buys New Shares in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Dynamic Technology Lab Private Ltd acquired a new stake in DENTSPLY SIRONA Inc., purchasing 24,531 shares valued at approximately $366,000 during the first quarter of the year.
• A series of institutional investors increased their positions in DENTSPLY SIRONA, with Vanguard Group Inc. owning the largest stake of over 20.7 million shares.
• Analysts have lowered price targets on DENTSPLY SIRONA, with the average consensus now at $18.64, reflecting a mixed outlook as several firms reduced their ratings.

Dynamic Technology Lab Private Ltd bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 24,531 shares of the medical instruments supplier's stock, valued at approximately $366,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter worth about $25,000. Brooklyn Investment Group purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock worth $34,000 after purchasing an additional 2,241 shares in the last quarter. Finally, Allworth Financial LP lifted its stake in shares of DENTSPLY SIRONA by 175.8% in the 1st quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock valued at $54,000 after acquiring an additional 2,517 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

XRAY has been the subject of a number of recent research reports. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. UBS Group lowered their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock traded up $0.05 on Wednesday, reaching $13.67. The stock had a trading volume of 387,315 shares, compared to its average volume of 2,970,970. The stock has a market cap of $2.73 billion, a P/E ratio of -2.88, a price-to-earnings-growth ratio of 0.85 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.48. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The company has a 50 day simple moving average of $14.63 and a 200 day simple moving average of $14.97.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company's revenue for the quarter was down 4.9% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.7%. DENTSPLY SIRONA's payout ratio is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.